1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Libbs Farmacêutica Ltda is currently overseeing a company patent portfolio that includes 1 pending office action. The prosecution of this portfolio is notably centralized, as it involves 1 distinct examiner. This suggests that the company's current interactions with the patent office are limited to a single point of contact, which can simplify the management of legal responses and prosecution timelines for the 1 pending office action.
The portfolio is associated with 0 distinct art units according to the current data. This lack of art unit classification may reflect a unique administrative status or a very specific technical niche that has not been broadly distributed across the patent office's organizational structure. Despite the absence of multiple art units, the presence of 1 pending office action confirms that the company is actively seeking to protect its innovations through the patent system.
HUI, SAN MING R serves as the busiest examiner for this portfolio, handling 1 busiest examiner pending office action. This examiner's role is critical, as they are the sole individual reviewing the company's pending claims. With 1 distinct examiner and 1 pending office action, the prosecution strategy is entirely dependent on the specific feedback and requirements provided by this examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUI, SAN MING R | 1 | 59.5% | +20.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18569621 | PHARMACEUTICAL COMPOSITION AND USE OF THE PHARMACEUTICAL COMPOSITION | HUI, SAN MING R | 8d overdue |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18569621 | PHARMACEUTICAL COMPOSITION AND USE OF THE PHARMACEUTICAL COMPOSITION | HUI, SAN MING R | — | §103 | Final Rejection | 8d overdue | Pending | Dec 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial